Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANGLIA trial of cannabidiol adjunctive treatment in recent-onset schizophrenia
NL-OMON47069Completed
- Sponsor
- Partner Psychiatrie
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in schizophrenia, schizophreniform disorder, schizoaffective disorder and 1 more comparing Cannabidiol adjunctive treatment with Placebo adjunctive treatment (2 arms). Started Nov 2017; status: completed.
02
Drugs
cannabidiol
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorderSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON47069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47069.